Displaying drugs 176 - 200 of 12696 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| XEN-D0501 | Not Annotated |  | XEN-D0501 is a tetrahydronaphthyl urea-based selective TRPV1 antagonist being investigated for the treatment of erythromelalgia. | Not Annotated |
| DLO6001 | Not Available |  | Investigated for use/treatment in parkinson's disease. | Not Available |
| rGLP-1 | Not Available |  | Investigated for use/treatment in congestive heart failure and diabetes mellitus type 2. | Recombinant Fusion Proteins |
| DLO6002 | Not Available |  | Investigated for use/treatment in parkinson's disease. | Not Available |
| R3R01 | Not Annotated |  | R3R01 is an investigational lipid-modifying drug. | Not Annotated |
| LX6171 | Not Available |  | Investigated for use/treatment in alzheimer's disease, attention deficit/hyperactivity disorder (ADHD), dementia, neurologic disorders, and schizophrenia and schizoaffective disorders. | Not Available |
| PRTX-100 | Not Available |  | Investigated for use/treatment in autoimmune diseases, inflammatory disorders (unspecified), rheumatoid arthritis, and thrombocytopenia. | Not Available |
| Norclobazam | Not Annotated |  | Not Annotated | Anticonvulsants |
| Dihydroquinidine barbiturate | Not Available |  | Not Available | Not Available |
| BTA798 | Not Available |  | Investigated for use/treatment in viral infection. | Not Available |
| Tocopherol | Not Available |  | Tocopherol can be used as a dietary supplement for patients with a deficit of vitamin E; this is mainly prescribed in the alpha form. Vitamin E deficiency is rare, and... | Vitamins |
| AS1409 | Not Available |  | Investigated for use/treatment in kidney cancer and melanoma. | Not Available |
| Ferumoxsil | Not Annotated |  | Not Annotated | Superparamagnetic Contrast Media |
| Poloxamer 407 | Not Annotated |  | Poloxamer 407 is a polyoxyethylene polymer and hydrophilic non-ionic surfactant. It consists of a central hydrophobic block of polypropylene glycol that is flanked on each side by polyethylene glycol blocks,... | Excipients / Polyethylene Glycols / Surface-Active Agents |
| Utidelone | Not Annotated |  | Utidelone (UTD1), a novel microtubule stabilizing agent, is an epothilone B analogue produced by genetic engineering.[A257544,A257549] It is under investigation in clinical trials for various cancers. | Not Annotated |
| MLN0415 | Not Available |  | Investigated for use/treatment in inflammatory disorders (unspecified). | Not Available |
| Contulakin-G | Not Annotated |  | Investigated for use/treatment in pain (acute or chronic). | Amino Acids, Peptides, and Proteins / Nerve Tissue Proteins / Peptides / Proteins |
| Dextran | Not Available |  | A low molecular weight dextran used as an adjunctive treatment of shock or impending shock due to hemorrhage, burns, surgery or other trauma, as well as the prophylaxis of venous thrombosis and pulmonary embolism during high-risk medical procedures. | Blood Substitutes and Plasma Protein Fractions |
| Ferumoxides | Not Annotated |  | Not Annotated | Contrast Media / Suspensions |
| Xanthan gum | Not Annotated |  | Xanthan gum is a polysaccharide gum derived from* Xanthomonas campestris* by a pure-culture fermentation process and purified by recovery with isopropyl alcohol. The major constituents include D-glucose, D-mannose, and D-glucuronic... | Drug Carriers / Food Additives |
| Ipecac | Not Available |  | An emetic agent used to induce vomiting in poisoning. | Antidotes / Expectorants |
| Tolevamer | Not Available |  | A potassium-binding resin used in the treatment of hyperkalemia. | Drugs for Treatment of Hyperkalemia and Hyperphosphatemia |
| XP12B | Not Available |  | Investigated for use/treatment in menstrual disorders. | Not Available |
| XL228 | Not Available |  | Investigated for use/treatment in leukemia (lymphoid) and leukemia (myeloid). | Not Available |
| DG031 | Not Available |  | Investigated for use/treatment in heart disease and myocardial infarction. | Not Available |
Displaying drugs 176 - 200 of 12696 in total